The Hollings Cancer Center has physician and research experts in every area of cancer who welcome the opportunity to speak to community groups upon request. If you would like a cancer expert to address your group, please contact Grace Hummel or call us at 843-792-0376.
Media requests made after hours, on weekends and on holidays, should be directed to the public relations representative on call, who can be contacted through the MUSC switchboard at 843-792-2123.
Preclinical studies show treatment of premalignant lesions with indomethacin, a drug similar to aspirin, increased the presence of immune cells and lessened tumor burden in head and neck cancer.
See recent peer-reviewed publications from HCC physicians, researchers and postdoctoral trainees.
Visit the News Center to see the latest news and feature events from the University, MUSC Health and local health care.